STOCK TITAN

Synergy Chc Stock Price, News & Analysis

SNYR NASDAQ

Company Description

Synergy CHC Corp. (NASDAQ: SNYR) is a healthcare-focused consumer products company that develops and markets consumer health and wellness brands. According to its public disclosures, Synergy positions itself as a consumer health and wellness company with a portfolio led by its flagship brands FOCUSfactor® and Flat Tummy®. The company is incorporated in Nevada and its common stock is listed on the Nasdaq Stock Market under the symbol SNYR.

Synergy CHC Corp. focuses on brain health, functional wellness, and women’s wellness and weight management. FOCUSfactor® is described in company materials as a clinically studied brain health supplement and functional beverage line with a long operating history. The brand includes dietary supplements and FOCUSfactor® Focus + Energy ready-to-drink functional beverages and brain-health energy shots. Flat Tummy® complements this portfolio as a lifestyle brand focused on women’s wellness and weight management.

Business model and distribution

Synergy CHC Corp. generates revenue from product sales, as reflected in its financial statements, and has also reported license revenue in prior periods. The company’s disclosures emphasize the marketing and distribution of consumer-branded products in the health and wellness space. FOCUSfactor® has established distribution in the United States, Canada, and the United Kingdom through major retailers. Company press releases note placements with Costco, Walmart, Amazon, BJ’s, Walgreens, and other mass, grocery, pharmacy, convenience, wholesale, and e‑commerce channels.

In addition to supplements, Synergy is building a functional beverage platform around FOCUSfactor® Focus + Energy drinks and brain-health shots. The company has entered into multiple Direct Store Delivery (DSD) partnerships with regional beverage distributors to expand retail availability of its beverages. Examples disclosed in press releases include agreements with Pine State Beverage in Maine, Fuhrer Beverage Company and Banko Beverage Co. in Pennsylvania, C&M Sales in Arkansas, Atlantic Importing Company in Southern New England, and AlaBev in Alabama. These distributors service grocery, convenience, specialty retail, and other outlets across their territories.

Geographic reach and channels

Company communications describe FOCUSfactor® as having an established footprint in the U.S., Canada, and the U.K., with ongoing expansion into additional markets. In North America, Synergy highlights retail authorizations and distribution partnerships with Kroger, Wakefern Food Corp. (parent of ShopRite and The Fresh Grocer), Uniprix in Canada, Fortinos, and Pilot Flying J. Internationally, a partnership with PriceSmart Inc. is expected to bring FOCUSfactor® Focus + Energy beverages to warehouse clubs across Central America, the Caribbean, and Colombia, according to company press releases.

Synergy has also reported the establishment of a wholly owned subsidiary in Mexico and initial shipments of its supplement products to Costco Mexico, as part of an international growth strategy focused on Mexico and broader Latin America. A Director of Sales & Marketing for Mexico & Latin America has been appointed to lead commercial strategy, market expansion, and go‑to‑market execution in that region.

Financial reporting and public company status

Synergy CHC Corp. is a smaller reporting company under U.S. securities laws, as disclosed in its registration statement on Form S‑1. The company files periodic and current reports with the U.S. Securities and Exchange Commission (SEC), including Form 10‑Q, Form 10‑K, and Form 8‑K. In its third quarter 2025 press release, Synergy reported product sales revenue, gross profit, operating income, net income, and non‑GAAP metrics such as EBITDA and Adjusted EBITDA. The company has also disclosed a public offering of common stock completed in August 2025, with proceeds intended for working capital and general corporate purposes.

Synergy’s financial disclosures emphasize ongoing profitability over multiple consecutive quarters, gross margin performance, and changes in working capital, inventory, and liabilities. The company also reports on non‑cash items, foreign currency adjustments, and stock‑based compensation as part of its reconciliation of GAAP to non‑GAAP measures.

Corporate governance and capital structure

Synergy CHC Corp. is incorporated in Nevada. Its SEC filings describe a Board of Directors and standard public company governance structures, including an Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee. In 2025, stockholders approved an amendment to the company’s 2024 Equity Incentive Plan to increase the number of shares available for issuance and an amendment to the Articles of Incorporation authorizing up to 1,000,000 shares of preferred stock. The company has also reported changes in board composition and executive roles, such as the appointment of a Head of Strategic Partnerships and a new director with extensive retail and pharmacy OTC experience.

Synergy’s capital structure includes common stock listed on Nasdaq under the symbol SNYR, and it has issued warrants to an underwriter in connection with a public offering, as described in its Form 8‑K. The company has discussed the use of equity incentives and underwriter warrants in its SEC filings and registration statements.

Brand positioning and recognition

Within the consumer health and wellness category, Synergy emphasizes brain health and cognitive performance as a core focus. FOCUSfactor® is described as a clinically studied brain health supplement with formulations aimed at memory, focus, and cognitive clarity. Company press releases state that FOCUSfactor® has a long legacy in the category and has been recognized as the #1 Pharmacist Recommended OTC Memory Supplement for 2025–2026 in a Pharmacy Times survey of pharmacists’ over‑the‑counter recommendations.

Synergy’s communications also highlight its strategy to expand FOCUSfactor® into the functional beverage market, with products positioned around clean energy, mental clarity, and brain‑health benefits. The company describes its beverages as part of the broader trend toward functional wellness and performance‑oriented consumer products. Flat Tummy® is presented as a lifestyle brand that broadens Synergy’s reach into women’s wellness and weight management.

Stock information and investor focus

Investors researching SNYR stock can find details about Synergy CHC Corp.’s operations, risk factors, and financial condition in its SEC filings, including its Form S‑1 registration statement and subsequent reports. The company identifies key risks related to competition in the consumer health and wellness market, reliance on third‑party manufacturers and suppliers, regulatory requirements for nutritional supplements, product safety and quality perceptions, and its ability to execute on expansion plans and maintain brand reputation.

Because Synergy operates in the consumer health and wellness sector with a focus on branded products, its performance is closely tied to retail distribution, brand recognition, and consumer demand for brain health, functional beverages, and women’s wellness products. Public disclosures emphasize the importance of retail partnerships, distribution networks, and international expansion in the company’s growth strategy.

Stock Performance

$—
0.00%
0.00
Last updated:
-64.48%
Performance 1 year
$14.9M

Financial Highlights

$30.0M
Revenue (TTM)
$2.1M
Net Income (TTM)
-$4.8M
Operating Cash Flow

Upcoming Events

APR
01
April 1, 2026 Product

Kroger supplements launch

Three supplement SKUs launch in 1,600 Kroger stores
APR
01
April 1, 2026 Operations

Walmart Canada SKU rollout

Walmart Canada to add 4 FOCUSfactor beverage SKUs (Original Orange, Berry, Rainbow Shaved Ice online, Pineapple Paradise online)
APR
01
April 1, 2026 Operations

McKesson Canada national rollout

McKesson Canada begins national rollout of FOCUSfactor beverages, expanding prior Q4 2025 supplement distribution.
JAN
01
January 1, 2027 Financial

Increase principal payments

Quarterly principal payments rise to $350,000 under term loan
MAY
01
May 1, 2029 Financial

Term loan maturity

$20M term loan facility matures with final repayment due

Short Interest History

Last 12 Months
Loading short interest data...

Short interest in Synergy Chc (SNYR) currently stands at 16.1 thousand shares, down 6.4% from the previous reporting period, representing 0.3% of the float. Over the past 12 months, short interest has increased by 88%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months
Loading days to cover data...

Days to cover for Synergy Chc (SNYR) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 3.2 days.

Frequently Asked Questions

What is the current stock price of Synergy Chc (SNYR)?

The current stock price of Synergy Chc (SNYR) is $1.3 as of February 26, 2026.

What is the market cap of Synergy Chc (SNYR)?

The market cap of Synergy Chc (SNYR) is approximately 14.9M. Learn more about what market capitalization means .

What is the revenue (TTM) of Synergy Chc (SNYR) stock?

The trailing twelve months (TTM) revenue of Synergy Chc (SNYR) is $30.0M.

What is the net income of Synergy Chc (SNYR)?

The trailing twelve months (TTM) net income of Synergy Chc (SNYR) is $2.1M.

What is the earnings per share (EPS) of Synergy Chc (SNYR)?

The diluted earnings per share (EPS) of Synergy Chc (SNYR) is $0.28 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of Synergy Chc (SNYR)?

The operating cash flow of Synergy Chc (SNYR) is -$4.8M. Learn about cash flow.

What is the profit margin of Synergy Chc (SNYR)?

The net profit margin of Synergy Chc (SNYR) is 7.1%. Learn about profit margins.

What is the operating margin of Synergy Chc (SNYR)?

The operating profit margin of Synergy Chc (SNYR) is 19.3%. Learn about operating margins.

What is the gross margin of Synergy Chc (SNYR)?

The gross profit margin of Synergy Chc (SNYR) is 78.8%. Learn about gross margins.

What is the current ratio of Synergy Chc (SNYR)?

The current ratio of Synergy Chc (SNYR) is 0.93, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of Synergy Chc (SNYR)?

The gross profit of Synergy Chc (SNYR) is $23.6M on a trailing twelve months (TTM) basis.

What is the operating income of Synergy Chc (SNYR)?

The operating income of Synergy Chc (SNYR) is $5.8M. Learn about operating income.

What does Synergy CHC Corp. do?

Synergy CHC Corp. develops and markets consumer health and wellness products. Its portfolio is led by FOCUSfactor®, a clinically studied brain health supplement and functional beverage line, and Flat Tummy®, a lifestyle brand focused on women’s wellness and weight management, according to the company’s public disclosures.

What are Synergy CHC Corp.’s main brands?

The company highlights two flagship brands: FOCUSfactor®, which includes brain health supplements and Focus + Energy functional beverages and shots, and Flat Tummy®, which is described as a lifestyle brand focused on women’s wellness and weight management.

How does Synergy CHC Corp. generate revenue?

Synergy reports revenue primarily from product sales of its consumer health and wellness brands. Its financial statements also show license revenue in certain periods, reflecting additional income streams related to its branded products.

Where are FOCUSfactor products sold?

Company press releases state that FOCUSfactor® has established distribution in the U.S., Canada, and the U.K. through major retailers such as Costco, Walmart, Amazon, BJ’s, and Walgreens, among others, and through additional mass, grocery, pharmacy, convenience, wholesale, and e‑commerce channels.

What is FOCUSfactor’s recognition in the memory supplement category?

According to a company press release, FOCUSfactor® was recognized as the #1 Pharmacist Recommended OTC Memory Supplement for 2025–2026 in a Pharmacy Times survey of pharmacists’ over‑the‑counter recommendations in the memory support category.

Is Synergy CHC Corp. a public company?

Yes. Synergy CHC Corp. is a public company with common stock listed on the Nasdaq Stock Market under the symbol SNYR. It files registration statements and periodic reports with the U.S. Securities and Exchange Commission as a smaller reporting company.

What is Synergy CHC Corp.’s corporate structure and jurisdiction?

Synergy CHC Corp. is incorporated in Nevada, as disclosed in its SEC filings. The company has authorized common stock and, following stockholder approval, has also authorized up to 1,000,000 shares of preferred stock under its Articles of Incorporation.

How is Synergy expanding its functional beverage business?

Synergy is building a national and international footprint for its FOCUSfactor® Focus + Energy beverages and brain-health shots through Direct Store Delivery partnerships with regional distributors such as AlaBev, Atlantic Importing Company, C&M Sales, Pine State Beverage, Fuhrer Beverage Company, and Banko Beverage Co., as described in its press releases.

What international growth initiatives has Synergy CHC Corp. disclosed?

The company has highlighted established distribution for FOCUSfactor® in the U.S., Canada, and the U.K., a partnership with PriceSmart to introduce FOCUSfactor® beverages across clubs in Central America, the Caribbean, and Colombia, and the formation of a wholly owned subsidiary in Mexico with initial shipments of supplements to Costco Mexico.

Where can investors find official financial information about Synergy CHC Corp.?

Investors can review Synergy CHC Corp.’s financial statements, risk factors, and other disclosures in its filings with the U.S. Securities and Exchange Commission, including its Form S‑1 registration statement and Form 8‑K reports that furnish quarterly earnings press releases.